LDHA and neoplasm: Pharmacological inhibition of LDHA with FX11 improved the infiltration and antitumor activity of cytotoxic lymphocytes while reducing the number of CAFs in tumors and suppressing PDAC tumor growth by inhibiting the growth of CAFs and normalizing the immune response (Figure 8).